| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 365 | 378 | 409 | 400 | 432 | 455 | 492 | 459 | 489 | 526 | 565 | 558 | 653 | 655 | 714 | 735 | 776 | 782 | 829 | 791 | 750 | 398 | 611 | 755 | 846 | 867 | 952 | 967 | 951 | 1,041 | 1,173 | 1,140 | 1,236 | 1,249 | 1,324 | 1,222 | 1,303 | 1,364 | 1,424 | 1,385 |
| Expenses | 326 | 344 | 360 | 358 | 392 | 402 | 426 | 406 | 425 | 473 | 502 | 502 | 597 | 607 | 640 | 657 | 676 | 675 | 702 | 684 | 659 | 486 | 575 | 648 | 698 | 728 | 774 | 787 | 768 | 842 | 898 | 874 | 946 | 963 | 997 | 925 | 985 | 1,037 | 1,092 | 1,060 |
| EBITDA | 39 | 34 | 49 | 42 | 40 | 54 | 66 | 53 | 64 | 53 | 63 | 56 | 56 | 49 | 74 | 79 | 101 | 107 | 127 | 107 | 92 | -87 | 36 | 107 | 148 | 139 | 179 | 180 | 182 | 200 | 275 | 266 | 290 | 286 | 327 | 297 | 318 | 327 | 332 | 325 |
| Operating Profit % | 10 % | 8 % | 11 % | 10 % | 8 % | 11 % | 13 % | 11 % | 12 % | 9 % | 10 % | 9 % | 8 % | 7 % | 10 % | 10 % | 12 % | 13 % | 15 % | 13 % | 11 % | -23 % | 4 % | 14 % | 17 % | 15 % | 18 % | 18 % | 18 % | 19 % | 21 % | 23 % | 23 % | 22 % | 24 % | 23 % | 23 % | 23 % | 22 % | 22 % |
| Depreciation | 19 | 18 | 18 | 19 | 21 | 19 | 20 | 20 | 21 | 22 | 29 | 24 | 26 | 33 | 34 | 35 | 36 | 41 | 43 | 46 | 55 | 46 | 46 | 47 | 45 | 45 | 46 | 46 | 47 | 48 | 49 | 57 | 56 | 59 | 55 | 63 | 65 | 62 | 65 | 70 |
| Interest | 12 | 9 | 8 | 6 | 6 | 6 | 5 | 6 | 6 | 10 | 8 | 8 | 21 | 17 | 18 | 18 | 18 | 22 | 22 | 21 | 21 | 20 | 19 | 19 | 18 | 17 | 17 | 16 | 16 | 15 | 15 | 19 | 21 | 21 | 23 | 25 | 28 | 34 | 35 | 37 |
| Profit Before Tax | 10 | 10 | 26 | 20 | 13 | 29 | 41 | 28 | 37 | 21 | 26 | 24 | 9 | -1 | 22 | 26 | 47 | 43 | 62 | 40 | 16 | -153 | -30 | 42 | 85 | 77 | 116 | 117 | 119 | 137 | 211 | 190 | 214 | 206 | 248 | 209 | 226 | 232 | 232 | 219 |
| Tax | 11 | 11 | 16 | 14 | 8 | 12 | 15 | 11 | 15 | 10 | 10 | 10 | -1 | 3 | 8 | 13 | 10 | 13 | 17 | 9 | 4 | -34 | -26 | 1 | 17 | 1 | 17 | 20 | 50 | 27 | 42 | 36 | 40 | 22 | 22 | 21 | 35 | 30 | 33 | 26 |
| Net Profit | -1 | -1 | 10 | 6 | 5 | 17 | 27 | 17 | 22 | 11 | 17 | 14 | 10 | -4 | 14 | 13 | 37 | 30 | 45 | 31 | 12 | -120 | -3 | 41 | 68 | 76 | 99 | 98 | 69 | 111 | 169 | 154 | 173 | 184 | 227 | 188 | 191 | 202 | 199 | 193 |
| EPS in ₹ | 0.00 | -0.03 | 0.52 | 0.29 | 0.25 | 0.85 | 1.31 | 0.84 | 1.10 | 0.54 | 0.82 | 0.70 | 0.48 | -0.21 | 0.67 | 0.63 | 1.83 | 1.49 | 2.23 | 1.55 | 0.59 | -5.90 | -0.17 | 2.01 | 3.35 | 3.75 | 4.89 | 4.80 | 3.40 | 5.45 | 8.31 | 7.57 | 8.53 | 9.06 | 11.16 | 9.26 | 9.39 | 9.92 | 9.78 | 9.50 |
Narayana Hrudayalaya
1,648.00
-24.05
(-1.44%)
Market Cap
33,678.66 Cr
EPS
38.86
PE Ratio
43.57
Dividend Yield
0.24 %
Industry
Healthcare Services52 Week High
1,724.35
52 Week Low
1,080.00
PB Ratio
10.65
Debt to Equity
0.50
Sector
Hospitals
Live Chart 
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from8 analysts
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
| 1,162.70 | 1,13,029.79 | 105.07 | 5,584.10 | 18.77 | 1,058 | -17.46 | 65.37 | |
| 6,651.00 | 95,631.18 | 72.60 | 19,165.50 | 14.74 | 917 | 49.14 | 62.72 | |
| 647.25 | 48,864.67 | 62.50 | 6,931.20 | 8.99 | 645 | 89.49 | 58.60 | |
| 1,260.00 | 33,842.01 | 65.17 | 2,759.20 | 25.09 | 326 | 15.71 | 56.75 | |
| 1,648.00 | 33,678.66 | 43.57 | 5,093.40 | 10.96 | 790 | 2.66 | 68.00 | |
| 646.45 | 25,866.98 | 73.54 | 2,511.20 | 12.94 | 336 | 20.76 | 70.04 | |
| 438.75 | 21,916.14 | 83.02 | 3,723.70 | 22.85 | 205 | -69.22 | 52.98 | |
| 1,341.65 | 13,624.68 | 57.92 | 1,334.00 | 10.76 | 218 | 10.06 | 57.97 | |
| 1,704.60 | 11,176.38 | 56.93 | 1,095.50 | 21.32 | 177 | 20.14 | 72.89 | |
| 531.65 | 7,411.35 | 136.75 | 1,929.10 | 12.97 | 41 | 129.41 | 67.81 |
Growth Rate
Revenue Growth
10.96 %
Net Income Growth
30.17 %
Cash Flow Change
-1.66 %
ROE
-3.76 %
ROCE
-15.58 %
EBITDA Margin (Avg.)
7.25 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 1,370 | 1,556 | 1,647 | 2,536 | 2,637 | 2,891 | 2,770 | 3,131 | 4,162 | 5,625 |
| Fixed Assets | 913 | 1,055 | 1,082 | 1,848 | 1,838 | 2,092 | 1,961 | 1,980 | 2,336 | 2,651 |
| Current Assets | 260 | 286 | 302 | 479 | 527 | 586 | 665 | 909 | 1,294 | 1,946 |
| Capital Work in Progress | 20 | 14 | 53 | 35 | 56 | 12 | 20 | 67 | 259 | 514 |
| Investments | 0 | 87 | 96 | 9 | 17 | 86 | 120 | 132 | 252 | 844 |
| Other Assets | 437 | 401 | 416 | 644 | 725 | 701 | 669 | 951 | 1,315 | 1,615 |
| Total Liabilities | 1,370 | 1,556 | 1,647 | 2,536 | 2,637 | 2,891 | 2,770 | 3,131 | 4,162 | 5,625 |
| Current Liabilities | 343 | 315 | 323 | 510 | 510 | 602 | 703 | 780 | 987 | 1,110 |
| Non Current Liabilities | 258 | 365 | 361 | 989 | 1,045 | 1,153 | 946 | 861 | 1,042 | 1,629 |
| Total Equity | 769 | 876 | 963 | 1,036 | 1,082 | 1,137 | 1,121 | 1,489 | 2,132 | 2,885 |
| Reserve & Surplus | 568 | 674 | 761 | 833 | 878 | 933 | 917 | 1,286 | 1,928 | 2,681 |
| Share Capital | 200 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | -6 | 42 | 28 | -22 | 89 | 8 | -2 | 59 | -4 | 97 |
| Investing Activities | -223 | -150 | -146 | -520 | -162 | -189 | -113 | -267 | -1,176 | -1,458 |
| Operating Activities | 77 | 174 | 219 | 182 | 279 | 443 | 304 | 485 | 1,085 | 1,067 |
| Financing Activities | 140 | 18 | -45 | 315 | -27 | -247 | -194 | -159 | 88 | 489 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
| Promoter | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 11.60 % | 0.00 % | 10.91 % | 10.01 % | 9.68 % | 9.44 % |
| DIIs | 14.80 % | 15.55 % | 16.15 % | 14.61 % | 13.76 % | 13.43 % | 16.18 % | 14.58 % | 14.14 % | 11.95 % | 10.89 % | 9.46 % | 9.51 % | 8.23 % | 7.90 % | 8.69 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.00 % | 0.00 % |
| Public / Retail | 4.64 % | 4.97 % | 4.85 % | 5.11 % | 5.92 % | 6.87 % | 5.86 % | 6.93 % | 7.10 % | 7.99 % | 8.46 % | 9.04 % | 10.00 % | 11.68 % | 12.13 % | 11.58 % |
| Others | 16.71 % | 15.63 % | 15.14 % | 16.43 % | 16.46 % | 15.85 % | 14.11 % | 14.64 % | 14.90 % | 16.20 % | 5.20 % | 17.65 % | 5.73 % | 6.23 % | 6.43 % | 6.43 % |
| No of Share Holders | 0 | 36,360 | 44,526 | 43,565 | 43,807 | 52,747 | 65,173 | 68,130 | 75,370 | 86,631 | 1,02,994 | 1,20,506 | 1,38,052 | 1,60,686 | 1,78,356 | 1,77,792 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 1 | 1 | 0.00 | 1 | 2.5 | 4 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.4 | 0.25 | 0.00 | 0.13 | 0.19 | 0.24 | 0.00 |
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Regulation 30_Intimation Regarding The Execution Of Joint Venture Agreement By Health City Cayman Islands A Wholly Owned Subsidiary Of The Company.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Intimation Under Regulation 30 Read With Para B Of Part A Of Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
Rumour verification - Regulation 30(11)
Announcement under Regulation 30 (LODR)-Allotment
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation Of Acquisition Of Shares By A Wholly-Owned Overseas Subsidiary Of The Company
Integrated Filing (Financial)
Announcement under Regulation 30 (LODR)-Investor Presentation
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Board Meeting Outcome for Outcome Of Board Meeting Held On February 14 2025
Result_Unaudited Financial Result For The Quarter And Nine Month Ended December 31 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Board Meeting Intimation for To Consider And Approve The Unaudited Standalone And Consolidated Financial Results For The Quarter Ended December 31 2024
Intimation Regarding Purchase Of Land At Bengaluru
Announcement under Regulation 30 (LODR)-Issue of Securities
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Announcement under Regulation 30 (LODR)-Credit Rating
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Report On Investor Complaints
Intimation Of Grant Of Insurer Certificate Permitting Cayman Integrated Healthcare Ltd. Foreign Step-Down Subsidiary Company To Offer Health Insurance To Residents Of The Cayman Islands
Announcement under Regulation 30 (LODR)-Newspaper Publication
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Announcement under Regulation 30 (LODR)-Acquisition
Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Announcement Under Regulation 30 Of SEBI Listing Regulation 2015 - Clarification On News Item Appearing In Mainstream Media
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Technical Indicators
RSI(14)
Neutral 68.00
ATR(14)
Less Volatile 65.44
STOCH(9,6)
Neutral 74.83
STOCH RSI(14)
Neutral 70.28
MACD(12,26)
Bullish 6.36
ADX(14)
Strong Trend 39.66
UO(9)
Bearish 49.24
ROC(12)
Uptrend And Accelerating 4.21
WillR(14)
Neutral -24.70
About Narayana Hrudayalaya
Narayana Hrudayalaya Limited is a healthcare company founded in 2000 by Dr. Devi Prasad Shetty. It operates a network of 23 multi-specialty and super-specialty hospitals, including 7 heart centers, across 18 locations in India and 1 in the Cayman Islands. The company provides a wide range of medical services, including cardiac sciences, oncology, gastroenterology, neurology, and pediatrics. Narayana Hrudayalaya has expanded its operations through acquisitions and partnerships, such as establishing a hospital in Nairobi, Kenya. The company is known for offering affordable quality care and has received NABH accreditation for multiple units. It became publicly listed on the BSE and NSE in January 2016.
Listing Date
06 Jan, 2016(9 Years,
19 days)
Chairperson NameDEVI PRASAD SHETTY
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
